The Twin Cities metro is home to some of the strongest and largest medical technology and device companies in the nation, ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

A live and archived webcast of the fireside chat will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

Indiana-based orthopedic companies welcomed nearly 1,000 8th-grade students to OrthoWorx’s DiscoverME program.

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

today announced the company will be participating in investor meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21, 2024.

Robert J Perna, SVP at Knowles KN, reported an insider sell on November 6, according to a new SEC filing. What Happened: Perna's decision to sell 21,080 shares of Knowles was revealed in a Form 4 ...

InfuSystem Holdings reported revenue of $35.3 million for the third quarter of 2024, an increase of 11% year over year.

Alcon reflected on its wholesale platform-based approach to clinical transformation during a session at the 2024 Veeva ...